Familial and attributable risks in cutaneous melanoma: Effects of proband and age

Journal of Investigative Dermatology

Volumn 120, Issue 2, 2003, Pages 217-223

  Hemminki, Kari ^a,b,c   Zhang, Hong ^a   Czene, Kamila ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c CNT Novum   (Sweden)

Author keywords

Heredity; In situ melanoma; Invasive melanoma; Parent offspring risks; Sibling risks

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER INVASION; CANCER REGISTRY; CARCINOMA IN SITU; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MELANOMA; PARENT; PRIORITY JOURNAL; PROGENY; SIBLING; AGE DISTRIBUTION; FAMILY HEALTH; GENETICS; MIDDLE AGED; PATHOLOGY; REGISTER; RISK FACTOR; SKIN TUMOR; SWEDEN;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FAMILY HEALTH; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; REGISTRIES; RISK FACTORS; SKIN NEOPLASMS; SWEDEN;

EID: 0037289784     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12041.x     Document Type: Article

References (69)

1. Adami J, Frisch M, Yuen J, Glimelius B, Melbye M: Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 370:1491-1495, 1995
2. Aitken J, Baailey-Wilson J, Green A, MacLennen R, Martin N: Segregation analysis of cutaneous melanoma in Queensland. Genet Epidemiol 15:391-401, 1998
3. Aitken J, Welch J, Duffy D, Milligan A, Green A, Martin N, Hayward N: CDKN2A variants in a population-based sample of Queensland families with melanoma. J Natl Cancer Inst 91:446-452, 1999
4. Ang C, Kelly J, Fritschi L, Dowling J: Characteristics of familial and non-familial melanoma in Australia. Melanoma Res 8:459-464, 1998
5. Berwick M, Vineis P: Markers of DNA repair and susceptibility to cancer in humans: an epidemiological review. J Natl Cancer Inst 92:874-897, 2000
6. Bishop DT, Demenais F, Goldstein AM, et al: Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 94:894-903, 2002
7. Borg A, Sandberg T, Nilsson K, et al: High frequency of multiple melanontas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 92:1260-1266, 2000
8. Brennan P, Coates M, Armstrong B, Colin D, Boffetta P: Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 82:1344-1349, 2000
9. Burden A, Newell J, Kavanagh G, Connor J, MacKie R: Genetic and environmental influences in the development of multiple primary melanoma. Arch Dermatol 135:261-265, 1999
10. Center for Epidemiology: Cancer Incidence in Sweden, 1998. In. Stockholm, 2000; pp 1-114
11. Cox NH, Aitchison TC, Sirel JM, MacKie RM: Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group. Br J Cancer 73:940-944, 1996
12. Czene K, Lichtenstein P, Hemminki K: Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99:260-266, 2002
13. Dong C, Hemminki K: Modification of cancer risks in offspring by sibling and parental cancers from 2, 112, 616 nuclear families. Int J Cancer 91:144-150, 2001a
14. Dong C, Hemminki K: Second primary neoplasms among 33 159 haematolympho-proliferative malignancy patients in Sweden, 1958-1996: a search for common mechanisms. Br J Cancer 85:997-1005, 2001b
15. Elwood J: Melanoma and ultraviolet radiation. Clin Dermatol 10:41-50, 1992
16. Elwood JM, Gallagher RP: Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure. Int J Cancer 78:276-280, 1998
17. English D, Armstrong B, Kricker A, Fleming C: Sunlight and cancer. Cancer Causes Control 8:271-283, 1997
18. Esteve J, Benhamou E, Raymond L: Statistical Methods in Cancer Research. Lyon: IARC, 1994
19. Fearon ER: Human cancer syndromes, clues to the origin and nature of cancer. Science 278:1043-1050, 1997
20. Frisch M, Melbye M: New primary cancers after squamous cell skin cancer. Am J Epidemiol 141:916-922, 1995
21. Gillgren P, Mansson-Brahme E, Frisell J, Johansson H, Larsson O, Ringborg U: Epidemiological characteristics of cutaneous malignant melanoma of the head and neck - a population-based study. Acta Oncol 38:1069-1074, 1999
22. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH: Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600-1607, 1994
23. Goldstein A, Tucker M: Genetic epidemiology of familial melanoma. Dermatol Clin 13:605-612, 1995
24. Greene M: The genetics of hereditary melanoma and ncvi: 1998 Update. Cancer 86(S11):2464-2477, 1999
25. Harland M, Meloni R, Gruis N, Pinney E, Brookes S, Spurr N, et al: Germline mutations of the CDKN2 gene in UK melanoma families. Hum Mol Genet 6:2061-2067, 1997
26. Hemminki K: Re: Genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 11:423, 2002
27. Hemminki K, Czene K: Attributable risks of familial cancer from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 2002, in press
28. Hemminki K, Dong C: Primary cancers following squamous cell carcinoma of the skin suggest involvement of Epstein-Barr virus. Epidemiology 11:94, 2000a (Letter)
29. Hemminki K, Dong C: Subsequent cancers after in situ and invasive squamous cell carcinoma of the skin. Arch Dermatol 136:647-651, 2000b
30. Hemmmki K, Jiang Y: Cancer risks among long-standing spouses. Br J Cancer 86:1737-1740, 2002
31. Hemminki K, Li X: A. population-based study of familial soft tissue tumors. J Clin Epidemiol 54:411-416, 2001
32. Hemminki K, Vaittinen P: Familial risks in in situ cancers from the Family-Cancer Database. Cancer Epidemiol Biomarkers Prev 7:865-868, 1998a
33. Hemminki K, Vaittinen P: National database of familial cancer in Sweden. Genet Epidemiol 15:225-236, 1998b
34. Hemminki K, Vaittinen P, Kyyrönen P: Age-specific familial risks in common cancers of the offspring. Int J Cancer 78:172-175, 1998
35. Hemminki K, Dong C, Vaittinen P: Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 20:247-257, 2001a
36. Hemminki K. Li X, Collins V: Parental cancer as a risk factor for brain tumors (Sweden). Cancer Causes Control 12:195-199, 2001b
37. Hemminki K, Lönnstedt I, Vaittinen P: A population-based study of familial cutaneous melanoma. Melanoma Res 11:133-140, 2001c
38. Hemminki K, Vaittinen P, Dong C, Easton D: Sibling risks in cancer: clues to recessive or X-linked genes? Br J Cancer 84:388-391, 2001d
39. Kennedy C, ter Huurne J, Berkhout M, et al: Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294-300, 2001
40. Kumar R, Smeds J, Berggren P, Straume O, Rozell BL, Akslen LA, Hemminki K: A single nucleoride polymorphism in the 3′ untranslated region of the CDKN2A gene is common m sporadic primary melanomas but mutations in the CDKN2B, CDKN2C, CDK4 and p53 genes are rare. Int J Cancer 95:385-393, 2001
41. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA, Landi G: Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 85:1304-1310, 2001
42. Landi MT, Baccarelli A, Tarone RE, Pesatori A, Tucker MA, Hedayati M, Grossman L: DNA repair, dysplastic nevi, and sunlight sensitivity in the development of cutaneous malignant melanoma. J Natl Cancer Inst 94:94-101, 2002
43. Levi F, Randimbison L, Te V, La Vecchia C: Non-Hodgkin's lymphoma, chronic lymphocytic leukaemias and skin cancers. Br J Cancer 74:1847-1850, 1996
44. Levi F, Randimbison L, La Vecchia C, Erler G: Te V: Incidence of invasive cancers following squamous cell skin cancer. Am J Epidemiol 146:734-739, 1997
45. Levi F, La Vecchia C, Te V, Randimbison L, Erler G: Incidence of invasive cancers following basal cell skin cancer. Am J Epidemiol 147:722-726, 1998
46. Mansson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U: Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol 41:138-146, 2002
47. Miettinen O: Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol 99:325-332, 1974
48. Peto J, Houlston R: Genetics and the common cancers. Enr J Cancer 37:88-S96, 2001
49. Platz A, Hansson J, Mansson-Brahme E, et al: Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma. J Natl Cancer Inst 89:697-702, 1997
50. Plna K, Hemminki K: Re: High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 93:323-324, 2001
51. Rees J: The melanocortin 1 receptor (MC1R): more than just red hair. Pigment Cell Res 13:135-140, 2000
52. Risch N: The genetic epidemiology of cancer: interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 10:733-741, 2001
53. Rothman K, Greenland S: Modern Epidemiology 2nd edn. Philadelphia: Lippincott-Raven, 1998
54. dos Santos Silva I: Coercer Epidemiology: Principles and Methods. Lyon: IARC, 1999
55. Schaffer J, Bolognia J: The melanocortin-1 receptor: red hair and beyond. J Invest Dermatol 137:1477-1485, 2001
56. Schenk M, Severson R, Pawlish K: The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma. Cancer 82:1672-1676, 1998
57. Staume O, Smeds J, Kumar R, Hemminki K, Akslen L: Significant impact of promoter hypermethylation and the 540 C>T polymorphism of CDKN2A in cutaneous melanoma of the vertical growth phase. Am J Pathol 161:229-237, 2002
58. Swerdlow A, Storm H, Sasieni P: Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 61:773, 1995
59. The Breast Cancer Linkage Consortium: Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst 91:1310-1316, 1999
60. Travis L, Curtis R, Boice JJ, Hankey B, Fraumeni JJ: Second cancers following non-Hodgkin's lymphoma. Cancer 67:2002-2009, 1991
61. Travis L, Curtis R, Glimelius B, et al: Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 85:1932-1937, 1993
62. van der Velden PA, Sandkuijl LA, Bergman W, Pavel S, van Mourik L, Frants RR, Gruis NA: Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 69:774-779, 2001
63. Wachsmuth RC, Gaut RM, Barrett JH, et al: Heritability and gene-environment interactions for melanocytic nevus density examined in a U.K. adolescent twin study. J Invest Dermatol 117:348-352, 2001
64. Wassberg C, Thorn M, Yuen J, Ringborg U, Hakulinen T: Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden. Br J Cancer 73:255-259, 1996
65. Wassberg C, Thorn M, Yuen J, Hakulinen T, Ringborg U: Cancer risk in patients with earlier diagnosis of cutaneons melanoma in situ. Int J Cancer 83:314-317, 1999a
66. Wassberg C. Thörn M, Yuen J, Ringborg U, Hakulinen T: Second primary cancers in patients with squamous cell carcinoma of the skin. Int J Cancer 80:511-515, 1999b
67. Xu G, Snellman E, Bykov VJ, Jansen CT, Hemminki K: Cutaneous melanoma patients have normal repair kinetics of ultraviolet-induced DNA repair in skin in situ. J Invest Dermatol 114:628-631, 2000
68. Zhao C, Snellman E, Jansen CT, Hemminki K: In situ repair of cyclobutane pyrimidine dimers in skin and melanocytic nevi of cutaneous melanoma patients. Int J Cancer 98:331-334, 2002
69. Zhu G, Duffy D, Eldridge A, et al: A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet 65:483-492, 1999